Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study | PLOS Medicine
Comparative effectiveness of valproic acid in different serum concentrations for maintenance treatment of bipolar disorder: A retrospective cohort study using target trial emulation framework - eClinicalMedicine
Mood Stabilizer - an overview | ScienceDirect Topics
When to adjust the dosing of psychotropics in patients with renal impairment | MDedge Psychiatry
Psych Meds 101: Mood Stabilizers - Mental Health @ Home
When to adjust the dosing of psychotropics in patients with renal impairment | MDedge Psychiatry
Depakote for Bipolar Disorder: Facts, Side Effects, Cost, Dosing
Lithium and chronic kidney disease: to stop or not to stop? - Velani - 2023 - Progress in Neurology and Psychiatry - Wiley Online Library
Mood stabilisers: helps against mood swings (bipolar disorder)
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial - The Lancet
Prediction of individuals at high risk of chronic kidney disease during treatment with lithium for bipolar disorder | BMC Medicine | Full Text
5 Common Bipolar Disorder Medication Issues
Mood stabilizers | Basicmedical Key
IJMS | Free Full-Text | Mood Stabilizers in Psychiatric Disorders and Mechanisms Learnt from In Vitro Model Systems
Lithium - Gateway Psychiatric
Kidney function in patients with bipolar disorder with and without lithium treatment compared with the general population in northern Sweden: results from the LiSIE and MONICA cohorts - The Lancet Psychiatry
How should you use the lab to monitor patients taking a mood stabilizer? | MDedge Psychiatry
Lithium (medication) - Wikipedia
Dosing for mood stabilizers in bipolar disor- der 2,8,36,40 | Download Table
What Are Mood Stabilizers?
Side effects of classic mood stabilizers | Download Table
JCM | Free Full-Text | The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines
Circadian biology to advance therapeutics for mood disorders: Trends in Pharmacological Sciences